The site is temporarily down due to maintenance. Sorry for the inconvenience. Synevo Tumor markers total prostate-specific antigen PSA. The latest technologies. It is synthesized in the cells of the prostate epithelium and secreted into the seminal fluid, which ensures the liquefaction of sperm.
PSA is a specific marker of prostate tissue, an increase in its level is observed in any inflammatory, benign, malignant, traumatic processes and during diagnostic and therapeutic manipulations. Therefore, it is important to determine it before any manipulation on the prostate gland: an increase is observed after biopsy of the gland the increased level persists for weeks , transurethral ultrasound examination, prostate massage and digital rectal examination.
Despite these limitations, PSA is the most widely used marker in the evaluation of prostate cancer, both for screening and diagnostics, as well as for monitoring. The incidence of CP depends on age.
Prostate cancer PSA-based screening is one of the most controversial topics in urology and oncology. Elevated PSA levels at the start of therapy are associated with a higher risk of recurrence.
PSA also plays an important role in monitoring prostate cancer at its various stages: monitoring, decision-making on therapeutic treatment, evaluation of prognosis and effectiveness of treatment surgical, hormonal. After radiotherapy, PSA levels gradually decline to a minimum after a few months. Free PSA does not provide relevant clinical information in the monitoring of prostate cancer, hence this The purpose of using the test is not recommended. Other tests. Purchase a test. Submission of material.
